LianMedical (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.0510
-0.00945 (-15.63%)
At close: Oct 9, 2026
LianMedical Market Cap
LianMedical has a market cap or net worth of $5.52 million as of October 9, 2026. It is the 44,606th most valuable company in the world and the 6,010th biggest in the United States. Its market cap has decreased by 7.78% in one year.
Market Cap
5.52M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#6,010 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 1, 2021, LianMedical's market cap has decreased from 1.44B to 5.52M, a decrease of -99.62%. That is a compound annual growth rate of -67.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 5.52M | -46.32% |
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncotelic Therapeutics | 9.61M |
| Zeo ScientifiX | 9.40M |
| Adaptimmune Therapeutics | 7.42M |
| OSR Health | 7.37M |
| Curative Biotechnology | 7.15M |
| VitaSpring Biomedical | 6.58M |
| Reviva Pharmaceuticals Holdings | 6.49M |
| TRON Group | 6.44M |